Alendate 70 Tablet is a prescription bisphosphonate medication used primarily for the treatment and prevention of osteoporosis in postmenopausal women and men. It is also indicated in glucocorticoid-induced osteoporosis and Paget’s disease of bone. By increasing bone mass and reducing bone loss, Alendate 70 Tablet helps lower the risk of fractures in the spine, hip, and other bones.

Alendronate works by inhibiting osteoclast activity, the cells responsible for bone resorption. This helps rebalance bone turnover in favor of bone formation, resulting in stronger, denser bones. The 70 mg once-weekly tablet is a convenient dosing format that improves patient compliance over daily therapy.

Commonly prescribed by endocrinologists, rheumatologists, and general physicians, Alendate 70 Tablet is part of a comprehensive bone health regimen, often combined with calcium and vitamin D supplements.

It is especially recommended for:

• Postmenopausal women with low bone mineral density (BMD)

• Men with osteoporosis or low testosterone

• Individuals on long-term corticosteroid therapy

• Patients with a history or high risk of osteoporotic fractures

This once-weekly tablet is clinically proven to improve bone density, reduce the frequency of fractures, and maintain long-term skeletal integrity. It supports mobility, independence, and quality of life in aging individuals.